$MDGL·4

SYNTA PHARMACEUTICALS CORP · Dec 9, 5:00 PM ET

SYNTA PHARMACEUTICALS CORP 4

4 · SYNTA PHARMACEUTICALS CORP · Filed Dec 9, 2015

Insider Transaction Report

Form 4
Period: 2015-12-07
Transactions
  • Sale

    Common Stock

    2015-12-08$0.38/sh300,000$114,0602,285,061 total(indirect: By Wyandanch Partners, L.P.)
  • Sale

    Common Stock

    2015-12-07$0.39/sh300,000$115,8302,585,061 total(indirect: By Wyandanch Partners, L.P.)
  • Sale

    Common Stock

    2015-12-09$0.38/sh145,892$55,2352,139,169 total(indirect: By Wyandanch Partners, L.P.)
Holdings
  • Common Stock

    (indirect: By IRA)
    175,000
  • Common Stock

    401,764
Footnotes (4)
  • [F1]This transaction was executed in multiple trades at prices ranging from $0.38 to $0.395 per share. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
  • [F2]The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, if any, and the inclusion of these shares in this report shall not be deemed an admission of the beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
  • [F3]This transaction was executed in multiple trades at prices ranging from $0.3617 to $0.3998 per share. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
  • [F4]This transaction was executed in multiple trades at prices ranging from $0.37 to $0.3839 per share. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.

Documents

1 file
  • 4
    edgar.xmlPrimary

    FORM 4 -